doi 10 1016/j. biopsych. 2009 . 10 . 009 pain or stress (9,JO); higher sensory and affective ratings of pain and a more negative internal affective state (10) ; dinlinished fear extinction (11); a potentiated startle reflex (12) ; higher amdety in women (13); higher incidence of major depression (14) but also with reduced generalized anxiety across adolescence, especially in interaction with a short 5-HTTLPR allele (15) ; less depreSSion in men (16) ; better performance in tests of frontal lobe function (for a review see [17] ); increased activation in the hippocampal formation and the ventrolateral prefrontal cortex in response to faces displaying negative emotion (18) ; improved processing efficiency in tlle prefrontal cortex and cingulate (8) ; and a lower P50 gating deficit in schizophrenia (19) . However, in spite of the strong influence of genotype on COMT activity, the relationship between the VaP 58 Met polymorphism and behavior, psychiatric disorders, and cognition has been found to be moderate (8, 16, 20) . In particular, a direct influence of the COMT VaP 5S Met polymorphism on the most Widely studied disorders-schizophrenia, bipolar disorder, substance dependence, obsessive-compulsive disorder, anorexia nervosa, and attention-deficit/hyperactivity disorder (ADHD)-has not been conclusively shown 07, 21) The relationship between the COMT VaP 58 Met polymorphism and various psychiatric disorders seems to be complex and might depend on gene-gene and/or gene-environment interactions.
Gene-environment interactions occur when the effect of exposme to an environmental pathogen on a person's health depends on his or her genotype (22)--for example, when the susceptibility to develop PTSD after traumatization depends on the interaction of trauma load with a certain genotype. Geneenvironment interactions have been reported for various elisorders (4, 22) . For the COMT VaP 58 Met polymorphism, carriers of the Val allele have been found to be at higher risk for psychotic symptoms and schizophreniform clisorder after cannabis consumption, whereas Met/Met homozygotes exhibited no such consequence of cannabis use (23 Met polymorphism in the development of PTSD (25) . In particular, possible gene-environment interactions between COMT genotype and traumatic load are, so far, unclear. In light of the present knowledge about the effects of COMT genotype, COMT gene-environment interactions, and the doseresponse effect of trawnatic load, Met/Met genotype carriers were hypothesized to be at higher risk to develop PTSD even after smaller numbers of different traumatic event types experienced than Val/Mctand Val/Val genotype carriers, which should manilestin a COMT gene-environment interaction on the probability of developing PTSD after cumulative traumatization.
Methods and Materials

Subjects
Four hWldred twenty-four Rwandese refugees (226 male, 198 female; mean age = 34.8 years, SD = 5.8, age range 17-68) from the 1994 Rwandan civil war who were living in the Nakivale refugee camp in southwestern Uganda were illvestigated. Because the Nakivale refugee camp has grown over the last decade and is spread over a large area, participants were sampled proportionally to the population size from each zone. To exclude genetic relatives in the samples, only one person/household was interviewed. Interviewers were trained to detect CWTent alcohol abuse and acute psychotic symptoms; candidates exhibiting these signs were excluded. All subjects had experienced multiple highly aversive traumatic situations and were examined ill 2006/ 2007 by trained experts with a structured interview based on the Posttraumatic Diagnostic Scale (PDS) (26) with the help of trained interpreters. Traumatic events were assessed with a checklist of 36 war-and non-war-related trawnatic event types (e.g., illjwy by weapon, rape, accident) (2, 27) . Traumatic load was estimated by assessing the number of different traumatic event types experienced or witr1essed. This measure is considered more reliable than assessing the frequency of traumatic events (2) . Depressive symptoms were assessed with the depression section of the Hopkins Symptom Checklist (HSCL-D) (28) A subset of this sample has been analyzed in previous studies (4, 27) . The procedures were approved by the Ethics Committee of the University of Konstanz, Germany, and the Ethics Committee of the Mbarara University of Science and Technology, Uganda.
The PDS and event list were completed ill the form of a standardized interview. Interviewers were first trained in a 6-week course on principles of quantitative data collection and intervievving techniques. Instruments were translated into Kin yarwanda vvith several steps of translations, blind back-translations, and subsequent corrections by independent groups of translators (29) . After dle translations, the psychometric properties of the translated scales were investiga ted in a validation study illcluding a retest spanning a 2-week period and a crossvalidation with expert rating (30) .
of the sample, 80.2% fulfilled criteria for lifetime and 48.SOi<l for current PTSD according to the DSM-IV (1). All but one subject had experienced at least one event fulfillillg the Al-and A2-criterion according to DSM-IV for a traumatic event. On average, 305 participants had experienced 12.6 different traumatic event types (SD = 5.0, range 0-25\ Saliva samples were obtained from each person with Oragene DNA Self-Collection Kit (DNA Genothek, Ottawa, Ontario, Canada). The DNA was extracted from saliva with standard protocols. The COMT genotype was analyzed by Pyrosequencillg. Please contact the authors for primer sequences and polymerase chain reaction conditions.
Statistics
Dependent variables (lifetime and current PTSD diagnosis as well as probability of remission from PTSD, defilled as "lifetime but not current PTSD") were analyzed vvith lOgistic lillear regressions widl the software package R (31). Further dependent variables were current PDS symptom subscales for intrusions, avoidance, and hyperarousal as well as current HSCL-D, which were analyzed with ordinary lillear regressions. We did not assess lifetime PDS symptom subscales or lifetime HSCL-D, because dlese symptoms cannot be reliably quantified retrospectively. The number of lifetime traumatic event types was modeled via a restricted cubic spline (32) to include possible nonlIDearities in the influence of traumatic load. Three knots were used, set at the 10%, 50%, and 90% quantiles of the covariate distribution (Table 2 .3 in [32] ). Nested models were compared vvith likelihood ratio (LR) tests (32); statistical significance was assessed by nonparametric permutation tests, with 10,000 random permutations (33) . All reported p values for LR, F and X 2 tests are one-tailed as always; for t tests and Kendall's 7 they are twotailed. See Supplement 1 for details on the statistical procedure. between traumatic load and frequency of lifetime PTSD of l'
Results
Subjects
.31, P <0001 for Val/Met genotypes and l' = .36, P <0001 for Val/Val genotypes. There was little difference in PTSD prevalence bet\veen genotypes beyond 15 traumatic event types. There was no significant main e1Tect of gender or significant interactions of gender X genotype or gender X traumatic load on the probability of suffering from lifetime PTSD, all p > .46 The probability of suffering from current PTSD, the current symptom severity as measured by tile PDS, and the proba bility of remission from lifetime PTSD exhibited neither genotype group effects nor interactions with traumatic load, all p > .06.
There was a significant main effect of traumatic load on HSCL-D (LR = 45.20, P < .0001) but no main effect of genotype (LR = .62, P = .73) or a significant interaction of t.ralillutic load X genotype (LR 694, P = .14). Similarly, tllere was a Significant main effect of HSCL-D on lifetime PTSD probability (LR = 70.05, P <0001) but no main efIect of genotype (LR = 4.13, P = .14) or a sigilltlcant interaction of traumatic load X genotype (LR = 5.06, P = .32)
Discussion
The results indicate a gene--environment interaction between the hwnan COMT VaP 58 111et polymorphism and the number of traumatic event types experienced in the risk of developing PTSD. Although Val allele carriers show a typical dose-response relationship benveen traumatic load and probability of developing PTSD, Met/Met homozygotes show a high risk for PTSD independently of the severity of tJaumatic load. This finclin~ is in line with previous reports on the effects of the COMT VajI>8Met polymorphism: the Met/Met genotype is related to reduced extinction of conditioned fear (11) , and the Met allele has been associated with higher reactivity to unpleasant visual stimuli and lower emotional resilience against negative mood states (8) and with higher sensitivity to pain stress (9).
Altllough it is not possible to draw any causal condusion from the findings of a genetic association study, we speculate that the underlying mechanisms of the COMT VaP 58 Met polymorphism with regard to PTSD might involve altered dopaminergic and noraclrenergic transmission in corticolimbic brain circuitry. Imaging genetics studies have shown that the Met allele, which is associated with lower enzyme activity and thus with higher dopamine levels (5, 6) , is related to increased brain activity in the ventrolateral prefrontal cortex, hippocampus, and amygdala (18, 34) . This neural circuitry has been implicated in anxiety and traumatic memory (35, 36) . Therefore, increased reactivity of brain circuitry implicated in generating and regulating affective responses of COMT Met/Met carriers might underlie their high risk for PTSD even at small trallllatic load. For instance, reduced norepinephrine metabolism in Met allele carriers might lead to an increased risk for PTSD after trauma via an increased amygdala fear response, as has been found because of inhibited norepinephrine reuptake (37) When studying gene-environment interactions, one complication needs to be addressed: does tile gene under consideration moderate not only individuals' response to the environment but also--by influencing their behavior-their exposure to envirorunental risk factors? This would change PTSD prevalence tlu'ough a different route than enhanced vulnerability after stressors (38, 39) . However, the present finding that there were no differences in the number of traumatic event types experienced between the genotype groups indicates that the COMT VaP 58 Met polymorphism. did not lead to altered risk behavior in our sample.
A ditTerent common problem in genetic association studies specific to PTSD is tlut it is unclear how many individuals in a "healthy" (non-PTSD) group might have developed PTSD if they had experienced one or "enough" different trm.lllatic event types (38, 40) , increasing the danger of false-negative results (41) . In this study, the sample consisted of a highly trawnatized population, so it was possible to compare persons who had developed PTSD after experiencing trm.lllatic events to severely traumaexposed control subjects without PTSD. whereas current PTSD was not? First we have to consider that a large number of participants with lifetime PTSD remitted spontaneously in the intervening 12 to 13 years between the genocide and our assessment. Furthermore, in a similar and overlapping sample, patients with lower traumatic load were found to have a higher probability of spontaneous remission (Kolassa et aI, unpublished observation), which might have erased genotype effects on current PTSD in the present study. The Met/Met homo zygotes were found to be at highest risk of PTSD even after low tramnatization, which is in accordance with previous studies that found higher susceptibility to anxiety disorders in Met allele carriers (10, 11, 13 )' However, several previous studies also found the Val allele to be associated with higher risk for various psychopathologies and with more abnormality in certain psychopathology-relevant biological measures (15) (16) (17) 19, 23, 24) Thus, the role of the COMT Val
158
Met single nucleotide polymorphism (SNP) in psychopathology might be quite different, depending on the diagnosis (42), which tmderscores that a given allele cannot be generally considered "better" or "worse" with regard to psychopathology (43) .
The allelic frequencies of the COMT VaP 58 Met SNP in our sample of Hutu and Tutsi individuals are very similar to those reported for other sub-Saharan populations like Y oruba, Ibo, Hausa, and Chagga (44,45) (Hapmap project). Although the gross pattern of linkage disequilibrium in the genomic region harboring COMT is similar between Caucasian and African populations, pairwise analyses suggest that the linkage of the VaP 58 Met SNP with other potentially functional variants of the COMT gene in intronic and regulatory regions might vary between populations with different ethnic and genetic background. Therefore, future studies with special focus on a dense genomic characterization of the COMT locus in several populations are needed to identify possible main and interacting SNP effects.
In conclusion, subjects homozygous for the Met allele of the COMT Val
Met polymorphism were found not to be subject to the cumulative effect of PTSD development, where multiple trauma types accumulate to increase the probability of developing PTSD, but to be highly likely to develop PTSD even after velY few tratunatic event types. This effect is not due to a selection effect of subjects homozygous for the Met allele to have experi· enced more traumatic events than other participants; therefore it does not seem to be mediated by a higher propensity to experience tratunatic situations. Still, it should be kept in mind that the relationship between homozygOSity for the Met allele and PTSD is by no means deterministic but rather one of increased susceptibility only, as shown by a ntmlber of traumatized Met/Met homozygotes who did not suffer from PTSD.
limitations to the present study include the small number of Met/Met genotypes in our sample. Furthermore, it was not possible to screen participants for all possible axis I comorbidities, because none of the comprehenSive international interviews covering all axis I disorders had been fully tested for reliability and validity in the studied or a comparable population. Futme studies should include validated measures of axis I disorders and might elucidate the neural mechanisms that underlie the observed gene-environment interaction with regard to dle risk of 
